These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 31634791)

  • 1. The Impact of Pharmaceutical Policies on Medicine Procurement Pricing in Indonesia Under the Implementation of Indonesia's Social Health Insurance System.
    Anggriani Y; Ramadaniati HU; Sarnianto P; Pontoan J; Suryawati S
    Value Health Reg Issues; 2020 May; 21():1-8. PubMed ID: 31634791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of Jaminan Kesehatan Nasional (JKN) on the cost of delivery services in Indonesia.
    Nugraheni WP; Mubasyiroh R; Hartono RK
    PLoS One; 2020; 15(7):e0235176. PubMed ID: 32614846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of pricing policy on the prices and supply of low-cost medicines in Shandong, China: evidence from an interrupted time series analysis.
    Rong X; Yin J; Duan S; Sun Q; Babar ZU
    BMC Public Health; 2020 Apr; 20(1):588. PubMed ID: 32349722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.
    Fang Y; Wagner AK; Yang S; Jiang M; Zhang F; Ross-Degnan D
    Lancet Glob Health; 2013 Oct; 1(4):e227-37. PubMed ID: 25104348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sensitivity of hospital coding to prices: evidence from Indonesia.
    Chalkley M; Hidayat B; Ramadani RV; Aragón MJ
    Int J Health Econ Manag; 2022 Jun; 22(2):147-162. PubMed ID: 34491464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indonesia: On the Way to Universal Health Care.
    Mboi N
    Health Syst Reform; 2015 Feb; 1(2):91-97. PubMed ID: 31546309
    [No Abstract]   [Full Text] [Related]  

  • 7. Pricing policies for generic medicines in Australia, New Zealand, the Republic of Korea and Singapore: patent expiry and influence on atorvastatin price.
    Roughead EE; Kim DS; Ong B; Kemp-Casey A
    WHO South East Asia J Public Health; 2018 Sep; 7(2):99-106. PubMed ID: 30136668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [International reference prices and cost minimization analysis for the regulation of medicine prices in Colombia].
    Vacca C; Acosta A; Rodriguez I
    Value Health; 2011; 14(5 Suppl 1):S16-9. PubMed ID: 21839891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National health insurance contribution to family planning program funding in Indonesia: A fund flow analysis.
    Wahdi AE; Sutanto E; Setyawan A; Astrini YP; Adani N; Mardani H; Maulana N; Pattnaik A; Trihono T; Wilopo SA
    Gates Open Res; 2023; 7():105. PubMed ID: 38605912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in Price of Cardiovascular and Diabetes Medicine in Indonesia, and Relationship with Quality: A Mixed Methods Study in East Java.
    Pisani E; Dewi A; Palagyi A; Praveen D; Ihsan BRP; Lawuningtyas Hariadini A; Lyrawati D; Sujarwoto ; Maharani A; Tampubolon G; Patel A
    Am J Trop Med Hyg; 2023 Jun; 108(6):1287-1299. PubMed ID: 37160275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appraisal of universal health insurance and maternal health services utilization: pre- and post-context of the Jaminan Kesehatan Nasional implementation in Indonesia.
    Rahmawati T; Hsieh HM
    Front Public Health; 2024; 12():1301421. PubMed ID: 38550326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Income Disparity and Healthcare Utilization: Lessons from Indonesia's National Health Insurance Claim Data.
    Nugroho ST; Ahsan A; Kusuma D; Adani N; Irawaty DK; Amalia N; Hati SRH
    Asian Pac J Cancer Prev; 2023 Oct; 24(10):3397-3402. PubMed ID: 37898843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How well does Malaysia achieve value for money in public sector purchasing of medicines? Evidence from medicines procurement prices from 2010 to 2014.
    Hamzah NM; Perera PN; Rannan-Eliya RP
    BMC Health Serv Res; 2020 Jun; 20(1):509. PubMed ID: 32503539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generic drug prices and policy in Australia: room for improvement? a comparative analysis with England.
    Mansfield SJ
    Aust Health Rev; 2014 Feb; 38(1):6-15. PubMed ID: 24480618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolution of Taiwan's National Health Insurance drug reimbursement scheme.
    Hsu JC; Lu CY
    Daru; 2015 Feb; 23(1):15. PubMed ID: 25889754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prices & availability of common medicines at six sites in India using a standard methodology.
    Kotwani A; Ewen M; Dey D; Iyer S; Lakshmi PK; Patel A; Raman K; Singhal GL; Thawani V; Tripathi S; Laing R
    Indian J Med Res; 2007 May; 125(5):645-54. PubMed ID: 17642500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does geographic spending variation exacerbate healthcare benefit inequality? A benefit incidence analysis for Indonesia.
    Sambodo NP; Van Doorslaer E; Pradhan M; Sparrow R
    Health Policy Plan; 2021 Aug; 36(7):1129-1139. PubMed ID: 34077516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of medicine pricing and reimbursement policies for universal health coverage in Indonesia.
    Wasir R; Irawati S; Makady A; Postma M; Goettsch W; Buskens E; Feenstra T
    PLoS One; 2019; 14(2):e0212328. PubMed ID: 30779809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Policy in Bulgaria.
    Dimova A; Rohova M; Atanasova E; Kawalec P; Czok K
    Value Health Reg Issues; 2017 Sep; 13():50-54. PubMed ID: 29073988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prices for generics in Australia - more competition might help.
    Bulfone L
    Aust Health Rev; 2009 May; 33(2):200-14. PubMed ID: 19563309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.